Anders Göransson
Corporate Officer/Principal at BACTIGUARD HOLDING AB
Net worth: 113 658 $ as of 29/04/2024
Profile
Anders Göransson is currently working as EVP & Global Head-Licensing at Bactiguard AB and as Head-Licensing & Executive Vice President at Bactiguard Holding AB.
He has a Master's degree in Business Administration from Suffolk University and a graduate degree from the University of Uppsala.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
BACTIGUARD HOLDING AB
0.06% | 30/12/2022 | 17,620 ( 0.06% ) | 113 658 $ | 29/04/2024 |
Anders Göransson active positions
Companies | Position | Start |
---|---|---|
BACTIGUARD HOLDING AB | Corporate Officer/Principal | 20/05/2023 |
Bactiguard AB
Bactiguard AB Medical DistributorsDistribution Services Bactiguard AB develops and supplies infection protection solutions to reduce the risk of hospital and healthcare related infections. Its product portfolio, Bactiguard Infection Protection, prevents bacterial adhesion and biofilm formation on medical devices. The firm's products include Infection Prevention Foley Catheter, Central Venous Catheter, and Endotracheal Tube. The company was founded by Nils Peder Christian Kinch on June 13, 2005 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | 22/05/2023 |
Training of Anders Göransson
University of Uppsala | Graduate Degree |
Suffolk University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BACTIGUARD HOLDING AB | Health Technology |
Private companies | 1 |
---|---|
Bactiguard AB
Bactiguard AB Medical DistributorsDistribution Services Bactiguard AB develops and supplies infection protection solutions to reduce the risk of hospital and healthcare related infections. Its product portfolio, Bactiguard Infection Protection, prevents bacterial adhesion and biofilm formation on medical devices. The firm's products include Infection Prevention Foley Catheter, Central Venous Catheter, and Endotracheal Tube. The company was founded by Nils Peder Christian Kinch on June 13, 2005 and is headquartered in Stockholm, Sweden. | Distribution Services |
- Stock Market
- Insiders
- Anders Göransson